Slow And Steady Wins The Race With Regencell Bioscience

Seeking Alpha

NEWS AND UPDATES         Slow And Steady Wins The Race With Regencell Bioscience Summary Regencell Bioscience is an early-stage bioscience company focused on the research, development, and commercialization of Traditional Chinese Medicine. Regencell Chairman and CEO, Yat-Gai Au recently purchased more than $5.9 million in RGC shares. Majority shareholders of Regencell are […]

The Top Performing IPO Stock Of 2021

NASDAQ

NEWS AND UPDATES               The Top Performing IPO Stock Of 2021   2021 was the busiest year for deals since 2000, with a record-breaking IPO rush of 1,035 listings in the US, with the biotech and healthcare sectors leading the way, accounting for 36% of all IPO activity. While […]

RGC CEO Figuratively Putting His Money Where His Mouth Is

Zacks SCR

NEWS AND UPDATES RGC CEO Figuratively Putting His Money Where His Mouth Is Investors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising interest rates, and the disruption of the war in Ukraine. The S&P 500 has come close to […]

Regencell Featured on ValueWalk

Value Walks

NEWS AND UPDATES Game-Stop Or Game-On? Regencell Has It All And Twice More Regencell Bioscience Limited’s (NASDAQ:RGC) stock is an undiscovered short squeeze potential. The  short volume ratio has similar pattern as that of GameStop Corp. (NYSE:GME), whereby both averaged  over 40% in the past year. In fact, RGC is more heavily shorted than GME as some […]

Regencell Featured on Benzinga

Benziga

NEWS AND UPDATES Traders May Keep Hunting For Another “Squeezable” Stock Like Gamestop CEO Elon Musk recently claimed that Microsoft Corp.  Co-Founder Bill Gates has a multibillion-dollar short position against his company. Musk suggested he doesn’t trust Gates and his stated commitment to addressing climate change, given his bets against Tesla. “Too often, sophisticated hedge funds have used […]

Over US$5 Million Ordinary Share Purchases by our CEO

NEWS AND UPDATES Over US$5 Million Ordinary Share Purchases by our CEO Mr. Yat-Gai Au, our Company’s Chairman and CEO, made purchases of ordinary shares in Regencell (“Ordinary Shares”) totaling $5.03 million. Based on his Schedule 13D filings with the U.S. Securities and Exchange Commission (the “SEC”) between July 27, 2021 and May 16, 2022, […]

Welcome Dr. William Wing-Yan Lo, JP to Become Our Board of Directors

NEWS AND UPDATES Welcome Dr. William Wing-Yan Lo, JP to Become Our Board of Directors We are delighted to have Dr. William Wing-Yan Lo, JP to become our Board of Directors, effective immediately.  He is an excellent addition to our board as he brings a wealth of strategic and leadership experience.  Welcome Dr Lo.   […]